H. Günthard

Most-cited papers

1. 2022 update of the drug resistance mutations in HIV-1.

   A. Wensing, V. Calvez, F. Ceccherini-Silberstein, C. Charpentier +4 more

   2022Topics in antiviral medicine601 citations

   Semantic Scholar

   Save

2. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA Panel.

   R. Gandhi, R. Bedimo, J. Hoy, R. Landovitz +14 more

   2022Journal of the American Medical Association (JAMA)536 citations

   Semantic Scholar

   Save

3. Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society-USA Panel.

   Rajesh T. Gandhi, Raphael J. Landovitz, Paul E Sax, Davey M. Smith +15 more

   2024Journal of the American Medical Association (JAMA)276 citations

   Semantic Scholar

   Save

4. Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial

   Wesley H. Uriel Cavan S. David M. Robert L. Michael Kevin Self Sandkovsky Reilly Vock Gottlieb Mack Golden D, W. Self, U. Sandkovsky, Cavan Reilly +496 more

   2021Lancet. Infectious Diseases (Print)156 citations Open access

   Semantic Scholar

   Save

5. Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium.

   B. Neesgaard, L. Greenberg, J. Miró, K. Grabmeier-Pfistershammer +27 more

   2022The Lancet HIV121 citations Open access

   Semantic Scholar

   Save

6. HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysis

   T. Loosli, S. Hossmann, S. Ingle, H. Okhai +14 more

   2023The Lancet HIV112 citations Open access

   Semantic Scholar

   Save

7. Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial

   Thomas L. Adit A. Roger Thomas A. Nicole Greg Andrew Noel Holland Ginde Paredes Murray Engen Grandits Vekste, T. Holland, A. Ginde, R. Paredes +100 more

   2022The Lancet Respiratory Medicine89 citations Open access

   Semantic Scholar

   Save

8. Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV

   A. Bick, K. Popadin, C. Thorball, M. Uddin +65 more

   2022Scientific Reports55 citations Open access

   Semantic Scholar

   Save

9. Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland

   P. Thoueille, Susana Alves Saldanha, F. Schaller, E. Choong +22 more

   2023The Lancet Regional Health - Europe54 citations Open access

   Semantic Scholar

   Save

10. Impact of Integrase Inhibitors on Cardiovascular Disease Events in People With Human Immunodeficiency Virus Starting Antiretroviral Therapy

    B. Surial, Frédérique Chammartin, J. Damas, A. Calmy +9 more

    2023Clinical Infectious Diseases47 citations Open access

    Semantic Scholar

    Save

11. 2025 update of the drug resistance mutations in HIV-1.

    Annemarie M. Wensing, V. Calvez, F. Ceccherini-Silberstein, C. Charpentier +5 more

    2025Topics in antiviral medicine46 citations

    Semantic Scholar

    Save

12. Epigenetic ageing accelerates before antiretroviral therapy and decelerates after viral suppression in people with HIV in Switzerland: a longitudinal study over 17 years.

    Isabella C. Schoepf, A. Esteban-Cantos, C. Thorball, B. Rodés +16 more

    2023The Lancet Healthy Longevity41 citations Open access

    Semantic Scholar

    Save

13. Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response

    M. Marconato, I. Abela, Anthony Hauser, Magdalena Schwarzmüller +19 more

    2022Journal of Clinical Investigation37 citations Open access

    Semantic Scholar

    Save

14. Antibody Response in Immunocompromised Patients After the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine BNT162b2 or mRNA-1273: A Randomized Controlled Trial

    B. Speich, Frédérique Chammartin, I. Abela, P. Amico +16 more

    2022Clinical Infectious Diseases36 citations Open access

    Semantic Scholar

    Save

15. Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration.

    Erich Tusch, L. Ryom, A. Pelchen-Matthews, A. Mocroft +32 more

    2024Clinical Infectious Diseases30 citations Open access

    Semantic Scholar

    Save

16. Recent abacavir use and incident cardiovascular disease in contemporary-treated people with HIV

    N. Jaschinski, L. Greenberg, B. Neesgaard, J. Miró +28 more

    2022AIDS (London)30 citations Open access

    Semantic Scholar

    Save

17. Hepatitis delta infection among persons living with HIV in Europe

    C. Béguelin, Andrew Atkinson, Anders Boyd, K. Falconer +8 more

    2023Liver international (Print)29 citations Open access

    Semantic Scholar

    Save

18. Predicted dolutegravir resistance in people living with HIV in South Africa during 2020-35: a modelling study.

    T. Loosli, N. Han, Anthony Hauser, Johannes Josi +13 more

    2025Lancet Global Health27 citations Open access

    Semantic Scholar

    Save

19. Factors Associated With Liver Steatosis in People With Human Immunodeficiency Virus on Contemporary Antiretroviral Therapy

    C. Riebensahm, A. Berzigotti, B. Surial, H. Günthard +4 more

    2022Open Forum Infectious Diseases25 citations Open access

    Semantic Scholar

    Save

20. Targeted shock-and-kill HIV-1 gene therapy approach combining CRISPR activation, suicide gene tBid and retargeted adenovirus delivery

    Sarah Klinnert, C. Schenkel, P. C. Freitag, H. Günthard +2 more

    2023Gene Therapy22 citations Open access

    Semantic Scholar

    Save

21. Sustained effect on hepatitis C elimination among men who have sex with men in the Swiss HIV Cohort Study: A systematic re-screening for hepatitis C RNA two years following a nation-wide elimination program.

    K. Kusejko, L. Salazar-Vizcaya, Cyril Shah, M. Stöckle +11 more

    2022Clinical Infectious Diseases22 citations Open access

    Semantic Scholar

    Save

22. High Rates of Asymptomatic Mycoplasma genitalium Infections With High Proportion of Genotypic Resistance to First-Line Macrolide Treatment Among Men Who Have Sex With Men Enrolled in the Zurich Primary HIV Infection Study

    Alexander Ring, S. Balakrishna, F. Imkamp, Sara Burkard +7 more

    2022Open Forum Infectious Diseases22 citations Open access

    Semantic Scholar

    Save

23. Plasma HIV-1 RNA and CD4+ T-cell counts are determinants of virological non-suppression outcomes with initial integrase inhibitor-based regimens: A prospective RESPOND cohort study.

    H. Álvarez, A. Mocroft, L. Ryom, B. Neesgaard +28 more

    2023Clinical Infectious Diseases18 citations Open access

    Semantic Scholar

    Save

24. Dissemination of Mycobacterium tuberculosis is associated to a SIGLEC1 null variant that limits antigen exchange via trafficking extracellular vesicles

    S. Benet, C. Gálvez, F. Drobniewski, I. Kontsevaya +27 more

    2021Journal of Extracellular Vesicles17 citations Open access

    Semantic Scholar

    Save

25. External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection.

    B. Surial, Adrià Ramírez Mena, M. Roumet, A. Limacher +11 more

    2023Journal of Hepatology15 citations Open access

    Semantic Scholar

    Save

26. Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19

    C. Barkauskas, E. Mylonakis, Garyfallia Poulakou, B. Young +101 more

    2022Annals of Internal Medicine14 citations Open access

    Semantic Scholar

    Save

27. Understanding the Decline of Incident, Active Tuberculosis in People With Human Immunodeficiency Virus in Switzerland

    Marius Zeeb, B. Tepekule, K. Kusejko, C. Reiber +14 more

    2023Clinical Infectious Diseases13 citations Open access

    Semantic Scholar

    Save

28. Canakinumab in patients with COVID-19 and type 2 diabetes – A multicentre, randomised, double-blind, placebo-controlled trial

    M. Hepprich, Jonathan M. Mudry, C. Gregoriano, F. Jornayvaz +22 more

    2022EClinicalMedicine13 citations Open access

    Semantic Scholar

    Save

29. Determinants of antibody response to severe acute respiratory syndrome coronavirus 2 mRNA vaccines in people with HIV.

    Frédérique Chammartin, K. Kusejko, C. Pasin, A. Trkola +16 more

    2022AIDS (London)11 citations Open access

    Semantic Scholar

    Save

30. HBV REPLICATION DURING TENOFOVIR THERAPY IS FREQUENT IN HIV/HBV-COINFECTION.

    E. Hofmann, B. Surial, N. Boillat-Blanco, H. Günthard +8 more

    2022Clinical Infectious Diseases11 citations Open access

    Semantic Scholar

    Save

31. Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2: Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2)

    Alexandra N. Griessbach, Frédérique Chammartin, I. Abela, P. Amico +21 more

    2023Open Forum Infectious Diseases10 citations Open access

    Semantic Scholar

    Save

32. Coronary Artery Disease-associated and Longevity-associated Polygenic Risk Scores for Prediction of Coronary Artery Disease Events in Persons Living with HIV: The Swiss HIV Cohort Study.

    Isabella C. Schoepf, C. Thorball, B. Ledergerber, Tanja Engel +14 more

    2021Clinical Infectious Diseases10 citations Open access

    Semantic Scholar

    Save

33. Sustained Viral Suppression With Dolutegravir Monotherapy Over 192 Weeks in Patients Starting Combination Antiretroviral Therapy During Primary Human Immunodeficiency Virus Infection (EARLY-SIMPLIFIED): A Randomized, Controlled, Multi-site, Noninferiority Trial

    Emily West, Marius Zeeb, Christina Grube, H. Kuster +9 more

    2023Clinical Infectious Diseases9 citations Open access

    Semantic Scholar

    Save

34. Quantifying and predicting ongoing Human Immunodeficiency Virus Type 1 (HIV-1) transmission dynamics in Switzerland using a distance-based clustering approach.

    Marco Labarile, T. Loosli, Marius Zeeb, K. Kusejko +15 more

    2022Journal of Infectious Diseases8 citations Open access

    Semantic Scholar

    Save

35. Impact of Latent Tuberculosis Infection on the Incidence of Type 2 Diabetes Mellitus in HIV-Infected Participants in the Swiss HIV Cohort Study.

    B. Tepekule, K. Kusejko, Marius Zeeb, P. Tarr +9 more

    2022Journal of Infectious Diseases8 citations Open access

    Semantic Scholar

    Save

36. Unsupervised machine learning predicts future sexual behaviour and sexually transmitted infections among HIV-positive men who have sex with men

    Sara Andresen, S. Balakrishna, C. Mugglin, A. Schmidt +11 more

    2022PLoS Comput. Biol.8 citations Open access

    Semantic Scholar

    Save

37. A systematic molecular epidemiology screen reveals numerous HIV-1 superinfections in the Swiss HIV Cohort Study.

    SE Chaudron, Christine Leemann, K. Kusejko, Huyen Nguyen +17 more

    2022Journal of Infectious Diseases8 citations Open access

    Semantic Scholar

    Save

38. Dolutegravir Monotherapy as Maintenance Strategy: A Meta-Analysis of Individual Participant Data From Randomized Controlled Trials

    A. Fournier, L. Hocqueloux, D. Braun, K. Metzner +10 more

    2022Open Forum Infectious Diseases8 citations Open access

    Semantic Scholar

    Save

39. Considerations and limitations for establishing an Intact Proviral DNA Assay (IPDA) on a chip-based digital PCR system for HIV-1 reservoir quantification.

    Jasmin Tschumi, Kathrin Neumann, Dominique L. Braun, H. Günthard +1 more

    2025Journal of Virological Methods7 citations Open access

    Semantic Scholar

    Save

40. HIV-phyloTSI: subtype-independent estimation of time since HIV-1 infection for cross-sectional measures of population incidence using deep sequence data

    T. Golubchik, L. Abeler-Dörner, Matthew D. Hall, C. Wymant +45 more

    2025BMC Bioinformatics7 citations Open access

    Semantic Scholar

    Save

41. T-Cell Exhaustion in HIV-1/Hepatitis C Virus Coinfection Is Reduced After Successful Treatment of Chronic Hepatitis C

    Kamila Caraballo Cortés, Sylwia Osuch, Karol Perlejewski, M. Radkowski +7 more

    2023Open Forum Infectious Diseases7 citations Open access

    Semantic Scholar

    Save

42. Population pharmacokinetics of rilpivirine following oral administration and long-acting intramuscular injection in real-world people with HIV

    P. Thoueille, Susana Alves Saldanha, F. Schaller, E. Choong +20 more

    2024Frontiers in Pharmacology6 citations Open access

    Semantic Scholar

    Save

43. Absence of Proviral Human Immunodeficiency Virus (HIV) Type 1 Evolution in Early-Treated Individuals With HIV Switching to Dolutegravir Monotherapy During 48 Weeks

    Lisa Jörimann, Jasmin Tschumi, Marius Zeeb, Christine Leemann +12 more

    2023Journal of Infectious Diseases6 citations Open access

    Semantic Scholar

    Save

44. Long‐term quantitative hepatitis B surface antigen (HBsAg) trajectories in persons with and without HBsAg loss on tenofovir‐containing antiretroviral therapy

    Lorin Begré, Anders Boyd, L. Salazar-Vizcaya, F. Suter-Riniker +12 more

    2023HIV Medicine6 citations Open access

    Semantic Scholar

    Save

45. Leukocyte Count and Coronary Artery Disease Events in People With Human Immunodeficiency Virus: A Longitudinal Study

    Emma F. Avery, Julia N. Kleynhans, B. Ledergerber, Isabella C. Schoepf +15 more

    2023Clinical Infectious Diseases6 citations Open access

    Semantic Scholar

    Save

46. Association of a Polygenic Risk Score With Osteoporosis in People Living With HIV: The Swiss HIV Cohort Study

    Johannes M. Schwenke, C. Thorball, Isabella C. Schoepf, L. Ryom +13 more

    2023Journal of Infectious Diseases6 citations Open access

    Semantic Scholar

    Save

47. The interplay between replication capacity of HIV-1 and surrogate markers of disease.

    Audrey E. Rindler, K. Kusejko, H. Kuster, Kathrin Neumann +7 more

    2022Journal of Infectious Diseases6 citations Open access

    Semantic Scholar

    Save

48. Developing and testing a Corona VaccinE tRiAL pLatform (COVERALL) to study Covid-19 vaccine response in immunocompromised patients

    K. Kusejko, Frédérique Chammartin, Dani M. Smith, M. Odermatt +8 more

    2022BMC Infectious Diseases5 citations Open access

    Semantic Scholar

    Save

49. Genetic Diversity From Proviral DNA as a Proxy for Time Since HIV-1 Infection

    Marius Zeeb, Paul Frischknecht, M. Huber, C. Schenkel +11 more

    2024Journal of Infectious Diseases4 citations Open access

    Semantic Scholar

    Save

50. Characterization and Determinants of Long-Term Immune Recovery Under Suppressive Antiretroviral Therapy

    T. Turk, Marco Labarile, D. Braun, A. Rauch +9 more

    2024Journal of Acquired Immune Deficiency Syndromes4 citations Open access

    Semantic Scholar

    Save